Douglas Adamson - Concepedia

Author

Douglas Adamson

Also Known As

D Adamson, D J A Adamson, D J Adamson, D. Adamson, D. J. A. ADAMSON, D. J. A. Adamson, D. J. Adamson, D.G. Adamson, D.J.A. ADAMSON, D.J.A. Adamson

Publications

Citations

H-Index

Concepts

All Affiliations

Ninewells Hospital University of Edinburgh University College London University of Southampton King's College London

About

Douglas Adamson is an author at Ninewells Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.8K
2	Health Sciences	5	5	1.4K
3	Engineering	1	1	117
4	Public Health	1	1	48
5	Biostatistics	1	1	117

Douglas Adamson

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study John Primrose, Richard Fox, Daniel H. Palmer, The Lancet Oncology Surgical OncologyGastrointestinal OncologyMedicineCancer ManagementBiliary Cancer	2019	1.2K
GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial Robert Leonard, Douglas Adamson, Gianfilippo Bertelli, Annals of Oncology Breast OncologyEarly Breast CancerMedicinePharmacologyGnrh Agonist	2017	149
Towards Predicting the Response of a Solid Tumour to Chemotherapy and Radiotherapy Treatments: Clinical Insights from a Computational Model Gibin Powathil, Douglas Adamson, Mark A. J. Chaplain PLoS Computational Biology EngineeringRadiation EffectRadiation ExposureTumor BiologyComputational Medicine	2013	117
Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT Nathan Coombs, Joel M Coombs, Uma J Vaidya, BMJ Open	2016	86
Diclofenac Antagonizes Peroxisome Proliferator-Activated Receptor-γ Signaling Douglas Adamson, David Frew, Roger Tatoud, Molecular Pharmacology	2002	84
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial Galina Velikova, Linda Williams, Sarah Willis, The Lancet Oncology Quality Of LifeSurgical OncologyRadiation TherapyMedicineBrachytherapy	2018	80
The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer Richard A. Anderson, J. Mansi, Robert E. Coleman, European Journal of Cancer	2017	72
Significant telomere shortening in childhood leukemia Douglas Adamson, Derek J. King, Neva E. Haites Cancer Genetics and Cytogenetics Hematological MalignancyChromatinMixed-phenotype Acute LeukemiaGeneticsChildhood Leukemia	1992	69
Randomized Double-Blind Trial of Pregabalin Versus Placebo in Conjunction With Palliative Radiotherapy for Cancer-Induced Bone Pain Marie Fallon, Peter Hoskin, Lesley Colvin, Journal of Clinical Oncology	2015	69
Imaging of the thorax in the management of germ cell testicular tumours Phil White, Douglas Adamson, G.C.W. Howard, Clinical Radiology Urogenital RadiologyGerm CellMedical ImagingHistopathologyGynecology	1999	65

Page 1